European Union approves BioNTech-Pfizer COVID vaccine | Coronavirus Update

The European Medicines Agency (EMA) approved the BioNTech-Pfizer coronavirus mRNA vaccine on Monday. It means the mass vaccination of some 450 million people across the EU is one step closer. EMA’s positive assessment of the vaccine was widely expected. EU countries are currently grappling with a fierce second wave of the virus. The Amsterdam-based drug regulator was under pressure from European countries, including Germany, to speed up its decision, which was originally scheduled for December 29. The recommendation applies to those of at least 16 years of age, EMA director Emer Cooke said. Aside from age, limitations also apply to pregnant women. As only limited data is available for that group, it should be assessed on a case-by-case basis whether it would be safe to give a jab, said Harald Enzmann, Chair of EMA Human Medicines Committee.